Category Archives for: NYSE:LLY

Eli Lilly Buys Migraine Treatment Specialist CoLucid For $960M In Cash

From StockNews.com: Eli Lilly and Co (NYSE:LLY) will acquire CoLucid Pharmaceuticals, a maker of a cutting edge migraine headache treatment, for $960 million, the two companies announced this morning.
ETF BASIC NEWS January 18, 2017 7:28am

Eli Lilly Shares Tank 15% As Alzheimer Drug Fails Clinical Trial

Drug making giant Eli Lilly and Co (NYSE:LLY) saw its shares plunge up to 15% in early trading Wednesday, after news broke that its key Alzheimer's treatment failed its latest clinical trial.
NYSE:LLY November 23, 2016 7:20am

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories